- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Mylan Bertek Pharmaceuticals
Total 437 results
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Belgium, Netherlands, France, Denmark, Israel, New Zealand, Australia, Ireland, Sweden, Canada, Germany, Poland, Switzerland, Italy, Austria, Hungary, Greece, Norway
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Spain, United Kingdom, Belgium, Netherlands, Denmark, Israel, New Zealand, France, Australia, Ireland, Germany, Sweden, Canada, Czechia, Switzerland, Portugal, Italy, Austria, Hungary, Norway, Poland, Greece
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, France, United Kingdom, Germany, Spain, Switzerland, Belgium, Israel, Netherlands, Denmark, Italy, Austria, Ireland, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedFocal Segmental Glomerulosclerosis (FSGS)United States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisFrance, Spain, Belgium, Netherlands, Australia, Italy, Czechia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Italy, Czechia, Switzerland, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Netherlands, United Kingdom, Germany, Portugal
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedAPOL1-mediated Kidney DiseaseUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisNetherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedTerminatedAlpha 1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, Australia, Germany, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedSmall Fiber NeuropathyUnited States, Netherlands, Germany, Italy
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Belgium, Denmark, Canada, Australia, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedOsteoarthritisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Spain, Germany, Italy, Austria, Belgium, Denmark
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Switzerland, Canada, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Australia, United Kingdom, Germany, Ireland
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Germany, Spain, Switzerland, Canada, Netherlands, Italy, Ireland, Sweden, France, Denmark
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis | Advanced Lung DiseaseUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, Germany, Canada, Netherlands, Czech Republic, Italy, Ireland, Sweden, United Kingdom, Australia, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Canada, Netherlands, Germany
-
Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicUnited States, Austria, Canada, Germany, Israel, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Vertex Pharmaceuticals IncorporatedCompletedHealthy | Hepatic ImpairmentSlovakia, Czech Republic
-
Vertex Pharmaceuticals IncorporatedApproved for marketingCystic Fibrosis
-
Vertex Pharmaceuticals IncorporatedCompletedIn Development for Cystic FibrosisCzech Republic, Slovakia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted